Aigh Capital Management LLC Cyclo Therapeutics, Inc. Transaction History

Aigh Capital Management LLC

  • $247 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 12, 2021
SELL
$6.58 - $10.85 $113,406 - $186,999
-17,235 Closed
0 $0
Q1 2021

May 13, 2021
SELL
$4.25 - $13.33 $1.41 Million - $4.44 Million
-332,765 Reduced 95.08%
17,235 $141,000
Q4 2020

Feb 16, 2021
BUY
$3.85 - $16.0 $1.35 Million - $5.6 Million
350,000 New
350,000 $1.52 Million

Others Institutions Holding CYTH

# of Institutions
20
Shares Held
2.25M
Call Options Held
0
Put Options Held
0
View Full List

About Cyclo Therapeutics, Inc.

CYTH Quotes by TradingView
  • Ticker CYTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 8,439,440
  • Market Cap $5.32M
  • Description
  • Cyclo Therapeutics, Inc., a clinical stage biotechnology company, develops cyclodextrin-based products for the treatment of various diseases. Its lead drug candidate is Trappsol Cyclo, an orphan drug, which is Phase III clinical trials for the treatment of Niemann-Pick Type C disease. The company also develops Trappsol Cyclo for the treatment of...
More about CYTH
Track This Portfolio

Track Aigh Capital Management LLC Portfolio

Follow Aigh Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aigh Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aigh Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email